分枝杆菌对利福平的敏感性。
Susceptibility of mycobacteria to rifampin.
作者信息
Woodley C L, Kilburn J O, David H L, Silcox V A
出版信息
Antimicrob Agents Chemother. 1972 Oct;2(4):245-9. doi: 10.1128/AAC.2.4.245.
Abstract
The Mycobacterium species M. tuberculosis, M. avium-intracellulare, M. kansasii, M. marinum, M. scrofulaceum, M. fortuitum, M. terrae, and M. gordonae were analyzed for their susceptibility to rifampin. M. tuberculosis, M. kansasii, and M. marinum were susceptible to the antibiotic, and resistant populations developed as a result of the interplay of mutation and selection. The mutation rates (susceptibility --> resistance) were calculated to be 4.9 x 10(-10) and 1.7 x 10(-9) mutations per bacterium per generation in, respectively, M. kansasii and M. marinum. M. fortuitum was found to be naturally resistant to the antibiotic, whereas the nature of resistance in the other species was unclear and is discussed.
摘要
对结核分枝杆菌、鸟分枝杆菌复合群、堪萨斯分枝杆菌、海分枝杆菌、瘰疬分枝杆菌、偶然分枝杆菌、地分枝杆菌和戈登分枝杆菌等分枝杆菌属菌种进行了利福平敏感性分析。结核分枝杆菌、堪萨斯分枝杆菌和海分枝杆菌对该抗生素敏感，耐药菌群体是突变与选择相互作用的结果。堪萨斯分枝杆菌和海分枝杆菌的突变率（敏感→耐药）经计算分别为每代每菌4.9×10⁻¹⁰和1.7×10⁻⁹个突变。发现偶然分枝杆菌对该抗生素天然耐药，而其他菌种的耐药性质尚不清楚并予以讨论。
相似文献
1
Susceptibility of mycobacteria to rifampin.分枝杆菌对利福平的敏感性。
Antimicrob Agents Chemother. 1972 Oct;2(4):245-9. doi: 10.1128/AAC.2.4.245.
2
In vitro susceptibility of atypical mycobacteria to rifampin.非结核分枝杆菌对利福平的体外药敏试验
Appl Microbiol. 1971 Jul;22(1):23-5. doi: 10.1128/am.22.1.23-25.1971.
3
Sensitivity of opportunist mycobacteria to rifampicin and ethambutol.机会性分枝杆菌对利福平和乙胺丁醇的敏感性。
Tubercle. 1981 Jun;62(2):117-21. doi: 10.1016/0041-3879(81)90019-2.
4
Spectrum of drugs against atypical mycobacteria: how valid is the current practice of drug susceptibility testing and the choice of drugs?抗非结核分枝杆菌药物谱：当前药物敏感性试验方法及药物选择的有效性如何？
Zentralbl Bakteriol. 1992 Dec;277(4):474-84. doi: 10.1016/s0934-8840(11)80472-x.
5
Characterization of rifampin-resistance in pathogenic mycobacteria.致病性分枝杆菌中利福平耐药性的特征分析。
Antimicrob Agents Chemother. 1994 Oct;38(10):2380-6. doi: 10.1128/AAC.38.10.2380.
6
Nontuberculous mycobacteria: susceptibility pattern and prevalence rate in Shanghai from 2005 to 2008.非结核分枝杆菌：2005 年至 2008 年上海的药敏模式和流行率。
Chin Med J (Engl). 2010 Jan 20;123(2):184-7.
7
Bactericidal activity of alkaline glutaraldehyde solution against a number of atypical mycobacterial species.碱性戊二醛溶液对多种非典型分枝杆菌的杀菌活性。
J Appl Bacteriol. 1986 Sep;61(3):247-51. doi: 10.1111/j.1365-2672.1986.tb04283.x.
8
In-vitro activity of seventeen antimicrobial compounds against seven species of mycobacteria.十七种抗菌化合物对七种分枝杆菌的体外活性。
J Antimicrob Chemother. 1988 Dec;22(6):857-61. doi: 10.1093/jac/22.6.857.
9
10
Performance Assessment of the BluePoint MycoID Plus Kit for Identification of Mycobacterium tuberculosis, Including Rifampin- and Isoniazid-resistant Isolates, and Nontuberculous Mycobacteria.用于鉴定结核分枝杆菌（包括耐利福平及异烟肼菌株）和非结核分枝杆菌的BluePoint MycoID Plus试剂盒性能评估
PLoS One. 2015 May 4;10(5):e0125016. doi: 10.1371/journal.pone.0125016. eCollection 2015.
引用本文的文献
1
Isolation and Antimicrobial Susceptibility of Nontuberculous Mycobacteria in a Tertiary Hospital in Korea, 2016 to 2020.2016年至2020年韩国一家三级医院非结核分枝杆菌的分离与药敏分析
Tuberc Respir Dis (Seoul). 2023 Jan;86(1):47-56. doi: 10.4046/trd.2022.0115. Epub 2022 Dec 8.
2
Combined Locked Nucleic Acid Probes and High-Resolution Melting Curve Analysis for Detection of Rifampicin-Resistant Tuberculosis in Northern Thailand.联合锁核酸探针与高分辨率熔解曲线分析用于泰国北部耐利福平结核病的检测
Diagnostics (Basel). 2022 Sep 24;12(10):2307. doi: 10.3390/diagnostics12102307.
3
Genetic and proteomic characterization of rpoB mutations and their effect on nematicidal activity in Photorhabdus luminescens LN2.rpoB 基因突变的遗传和蛋白质组学特征及其对发光杆菌 LN2 杀线虫活性的影响。
PLoS One. 2012;7(8):e43114. doi: 10.1371/journal.pone.0043114. Epub 2012 Aug 17.
4
Case of Mycobacterium marinum infection with unusual patterns of susceptibility to commonly used antibiotics.分枝杆菌感染病例，对常用抗生素的敏感性呈现不寻常模式。
J Clin Microbiol. 2011 May;49(5):2056-8. doi: 10.1128/JCM.02022-10. Epub 2011 Mar 23.
5
Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives.耐多药结核分枝杆菌：分子视角
Emerg Infect Dis. 1998 Apr-Jun;4(2):195-209. doi: 10.3201/eid0402.980207.
6
Rifampin disks in mycobacterial susceptibility testing.分枝杆菌药敏试验中的利福平纸片
Antimicrob Agents Chemother. 1975 Feb;7(2):222-5. doi: 10.1128/AAC.7.2.222.
7
Permeability barrier to rifampin in mycobacteria.分枝杆菌对利福平的通透性屏障
Antimicrob Agents Chemother. 1977 May;11(5):773-9. doi: 10.1128/AAC.11.5.773.
本文引用的文献
1
Mutations of Bacteria from Virus Sensitivity to Virus Resistance.细菌从对病毒敏感到对病毒抗性的突变。
Genetics. 1943 Nov;28(6):491-511. doi: 10.1093/genetics/28.6.491.
2
A Factor (or Mutator Gene) Influencing Mutation Rates in Escherichia Coli.一种影响大肠杆菌突变率的因子（或诱变基因）
Proc Natl Acad Sci U S A. 1954 Nov;40(11):1064-71. doi: 10.1073/pnas.40.11.1064.
3
Mutation and Adaptation of Phytomonas stewartii.斯图尔特氏植原体的突变与适应
J Bacteriol. 1947 Dec;54(6):745-57. doi: 10.1128/jb.54.6.745-757.1947.
4
Selective mechanisms in bacteria.细菌中的选择机制。
Cold Spring Harb Symp Quant Biol. 1951;16:345-55. doi: 10.1101/sqb.1951.016.01.026.
5
INDUCIBLE RESISTANCE TO ERYTHROMYCIN IN STAPHYLOCOCCUS AUREUS.金黄色葡萄球菌对红霉素的诱导抗性
J Bacteriol. 1964 Sep;88(3):574-80. doi: 10.1128/jb.88.3.574-580.1964.
6
MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE.分枝杆菌：药物敏感性和耐药性检测的实验室方法
Bull World Health Organ. 1963;29(5):565-78.
7
NEW TYPE OF STREPTOMYCIN RESISTANCE RESULTING FROM ACTION OF THE EPISOMELIKE MUTATOR FACTOR IN ESCHERICHIA COLI.大肠杆菌中类附加体突变因子作用导致的新型链霉素抗性
J Bacteriol. 1963 Sep;86(3):510-6. doi: 10.1128/jb.86.3.510-516.1963.
8
A strain of Escherichia coli with an unusually high rate of auxotrophic mutation.一株营养缺陷型突变率异常高的大肠杆菌。
J Bacteriol. 1955 Nov;70(5):588-95. doi: 10.1128/jb.70.5.588-595.1955.
9
In vitro susceptibility of mycobacteria to rifampin.
Am Rev Respir Dis. 1969 Aug;100(2):234-6. doi: 10.1164/arrd.1969.100.2.234.
10
Inhibition by fifampin of mycobacteriophage D29 replication in its drug-resistant host, Mycobacterium smergmatis ATCC 607.利福平对分枝杆菌噬菌体D29在其耐药宿主耻垢分枝杆菌ATCC 607中复制的抑制作用。
Am Rev Respir Dis. 1971 May;103(5):618-24. doi: 10.1164/arrd.1971.103.5.618.
Zotero 插件